Related Experiment Video
Updated: Aug 20, 2025

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Life-Long Steroid Responsive Familial Myopathy With Docking Protein 7 Mutation
Shin J Oh1, Peter H King1, Alice Schindler2
1Department of Neurology, University of Alabama at Birmingham, Birmingham, AL; and.
Abstract:
Docking protein 7 (DOK7) congenital myasthenic syndrome (CMS) is characterized by limb-girdle weakness and lack of fluctuating fatigability simulating many familial myopathies. Albuterol is the first line of therapy in view of consistent improvement. Two brothers with progressive predominant biceps weakness for 1-3 years responded to prednisone treatment for 40-50 years. Various studies including muscle biopsy and many laboratory studies were unsuccessful for the definite diagnosis. Gene study, 40 years after the initial evaluation, confirmed the diagnosis of DOK7 CMS. These are the first reported cases of DOK7 CMS associated with a sustained benefit from corticosteroids.
More Related Videos
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Lysosomal Hydrolases
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...

